Arixtra

Arixtra (fondaparinux) is a medication that helps prevent blood clots by inhibiting certain proteins involved in clot formation. It’s commonly used to reduce the risk of deep vein thrombosis, pulmonary embolism, or clot-related complications after surgeries or in hospitalized patients. Arixtra is administered via injection and works by targeting specific factors in the blood’s clotting process, making it effective in maintaining normal blood flow. It is typically prescribed by healthcare providers based on individual health needs and conditions, helping to lower the risk of dangerous blood clots without dissolving existing ones.